If you can't find what you want, Ask Us.

Refine Your Results


Filter by Category




Showing 1-20 of 976 results Sort by:


  • 1 Request Info

    Webinar on How to Use Social Media in Healthcare without Violating HIPAA Rules

    Learn how to use websites and social media for patient engagement in healthcare without violating HIPAA compliance. Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 Event link -
  • 2 Request Info

    How to Implement MDSAP-Requirements into your ISO 13485

    Overview: How a smart implementation of these requirements in the quality management system is possible and finally how the audit for five countries (Australia, Brazil, Canada, Japan, US) is working. Why should you Attend: Your implementation time should be short and need smart ideas to reach the right level to pass the MDSAP - Audit by your audit organization. Areas Covered in the Session: Which Companies must have MDSAP? Which Companies should have MDSAP? Which Companies should postpone MDSAP? What are the requirements of MDSAP?
  • 3 Request Info

    Data Integrity: Compliance with 21 CFR Part 11

    Overview: This webinar describes exactly what is required for compliance with Part 11 and the European equivalent Annex 11 for local, SaaS/Cloud hosted applications. Areas Covered in the Session: What 21 CFR Part 11 means today Purpose of Part 11 What does Part 11 mean? SOPs System features Infrastructure qualification Validation Who Will Benefit: GMP, GCP, GLP, Regulatory Professionals QA/QC IT Auditors Managers and Directors Software Vendors, Hosting Providers
  • 4 Request Info

    Strategies To Prevent Manufacture And Distribution Of Substandard Medications

    Overview: In this webinar we will provide you with best practices that have been proven effective, and equip you with the means to advocate for these ideas within your organization. Why should you Attend: If a legitimate product is not manufactured according to quality standards or becomes degraded as it travels through its supply chain, it can be ineffective at best or deadly at worst. Examples of potential dangers that can occur include temperature excursions, inappropriate use, and unsafe ingredients inadvertently added to the product.
  • 5 Request Info

    FDA's New Import Program for 2019

    Overview: In this interactive session author will discuss about the FDA's required information for the PREDICT software screening prior to entry and Custom's Harmonized Tariff Schedule (HTS). Why should you Attend: The new import entry filing requirements became effective in 2016 and are posing problems for user. Failure to provide the correct information creates costly delays and, in some cases, the frustrating task of contacting the FDA to resolve the problem.
  • 6 Request Info

    Test Method Validation to Verify the Performance of a Medical Device

    Overview: Those who work with process optimization and validation focus on optimizing a process and reducing variability. Those working on Test Method Validation, on the other hand, focus on discerning between process variation and measurement error from the test method itself. Why should you Attend: This webinar will help you better understand Test Method Validations to verify the performance of a Medical Device, global reference standards, the FDA requirements and how to perform successful TMV to ensure your inspection of verification is effective, using detailed real-life case studies.
  • 7 Request Info

    Audit Trail Generation and Review 2019

    Overview: These electronic records must be maintained according to regulatory requirements contained within FDA's 21 CFR Part 11 for US jurisdictions and Eudralex Volume 4 Annex 11 for EU jurisdictions. Why should you Attend: Attendees will learn how to review audit trails, using a risk based approach to cull through the thousands of audit trail records that can be generated on a daily basis.
  • 8 Request Info

    Compliance with the New ICH GCP Revision 2 Addendum

    This webinar will cover these new requirements for running clinical trials, update you on further revisions of ICH GCP R2 and evaluate the changes and discuss how these should have been implemented for sponsors, CROs/vendors and study sites. This will enable you to meet the new international GCP standard to ensure regulatory compliance and the acceptance of clinical trial data by the regulatory authorities internationally.
  • 9 Request Info

    Webinar on The Problem of Bacterial Spores and Sporicidal Disinfection

    Learn the origins and risks of spores, strategies to reduce incidents and incorporation of sporicidal agents into the contamination control program. Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 Event link -
  • 10 Request Info

    Seminar on Phase I GMPs

    Early clinical trials are conducted to establish initial safety of a drug. The studies are generally in small number of healthy subjects and use lower doses of the drug product. Therefore, only small amounts of investigational material are required. In order to not undertake substantial costs and to reduce regulatory burden during these early stages, the FDA has established guidelines to allow early stage investigational products to be manufactured under less stringent GMPs. More:
  • 11 Request Info

    Applied Statistics, with Emphasis on Verification, Validation, and Risk Management, in R&D, Manufacturing, and QA/QC

    The 2-day seminar explains how to apply statistics to manage risks and verify/validate processes in R&D, QA/QC, and Manufacturing, with examples derived mainly from the medical device design/manufacturing industry. The flow of topics over the 2 days is as follows: ISO standards and FDA/MDD regulations regarding the use of statistics. Basic vocabulary and concepts, including distributions such as binomial, hypergeometric, and Normal, and transformations into Normality. Statistical Process Control Statistical methods for Design Verification Statistical methods for Product/Process Qualification Metrology: QC Sampling Plans the statistical analysis of measurement uncertainty, and how it is used to establish QC specifications How to craft "statistically valid conclusion statements" (e.g., for reports) Summary recommendations More:
  • 12 Request Info

    Patient Communications, E-mail, and Texting - How to Meet Patient Requests for Information and Stay Within the HIPAA Rules

    This session will describe the information security compliance process, how it works, and how it can help you decide how to integrate e-mail and texting into your organization in a compliant way, learn how to use an information security management process to evaluate risks and make decisions about how best to protect PHI and meet patient needs and desires.
  • 13 Request Info

    Practical strategies for Meeting the Needs of Teens and Adolescents with ASD

    Overview: When working or living with an adolescent with an Autism Spectrum Disorder, meltdowns may occur that may be a result of sensory overload, cognitive overload or due to inability to self-regulate emotions. Communication skills impact social skills which then lead to behavior problems. Recognizing those signs which are the rumbling stages of an eruption may be the key to preventing more serious behaviors.
  • 14 Request Info

    Performing a Risk Assessment - Methodology and Steps for Success

    Overview: The Risk Assessment which is required by the HIPAA Security Rule is often overlooked, misunderstood, or it seems to be too complex to even find a starting point. What some organizations find out is that while they brought in a third party auditor to do a "IT network assessment' that they actually did not end up performing a full blow risk assessment.
  • 15 Request Info

    Treatment Planning for Mental Health Providers

    Overview: Clinical treatment planning in any mental health setting is often thought of as a necessary routine that must be completed in order to provide a guide for patient course. Practitioners may treat the planning process with a cavalier approach, particularly after having completed many plans within their clinical setting.This training is designed to assist both newly minted mental health practitioners as well as seasoned professionals. While the program is filled with practical steps, tools and advice, it also allows for creativity and independent critical thinking skills to be applied to the process. First, participants will learn the importance of investing in the treatment planning process in a manner that provides immediate continuity and connection with the patient and their presenting symptoms.This initial part of the training explains the FUN in treatment planning.
  • 16 Request Info

    Why Medication is Usually Contraindicated in the Treatment of Panic: What is 90% Effective

    Overview: Panic attacks are amongst the most dreaded of mental health problem. The most effective strategy for relieving panic attacks is interoceptive exposure (IE) which involves systematically bringing on the symptoms such that the person habituates and desensitizes to them.
  • 17 Request Info

    Ethical Challenges in a Digital World and Ethical Decision-making Strategies

    Overview: Today's behavioral health practitioners face a wide range of unprecedented ethical challenges related to their use of digital and other technology. Is it ethical for practitioners (mental health counselors,social workers, psychologists, psychiatrists, marriage and family therapists, and substance use counselors) to use technology to provide services remotely to clients they never meet in person?
  • 18 Request Info

    The FDA Inspection: Preparation, Management, and Follow - up

    Overview This is a detailed course designed to provide medical device/pharmaceutical professionals with the information they require to prepare for and manage FDA inspections.
  • 19 Request Info

    Implementation and Management of GMP Data Integrity

    Overview Data integrity is the assurance that data records are accurate, complete, intact and maintained within their original context, including their relationship to other data records. This definition applies to data recorded in electronic and paper formats or a hybrid of both. To assure the quality of raw materials, in process materials and finished goods, laboratory data integrity is assuming greater importance in current Good Manufacturing Practices (CGMP) for US Food and Drug Administration (FDA)-regulated industry. Data integrity and security infractions are not only 21 Code of Federal Regulations (CFR) Part 11 issues but also severe CGMP violations.
  • 20 Request Info

    What is Human Factors and why is it Important?

    Overview This webinar is tailored to provide an overview of human factors and the benefits of applying human factors within the design process and ongoing system operations.